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Antimicrobial resistance in bacteria is a growing global public health problem. In its latest report, the United States CDC estimated that at least 2 million people became infected with antimicrobial-resistant bacteria, and \>23,000 people die each year as a result ([@B1]). This rapid increase in antimicrobial resistance, coupled with the dwindling pipeline of effective antimicrobial armamentarium, has raised tremendous concern about the emergence of a doomsday organism. This concern is certainly warranted for the NDM-1-positive *Enterobacteriacae*, as bacteria that produce NDM-1 β-lactamase are typically resistant to a wide range of antibiotics, including carbapenems, one of the last-resort drugs for many bacterial infections ([@B2], [@B3]).

A 29-year-old male subject was admitted to Tan Tock Seng Hospital in 2010 for an accidental fall resulting in a 5th cervical spine fracture and spinal cord injury. He underwent surgical decompression, reconstruction, and stabilization with a good neurological outcome. The subject was in a rehabilitation ward with another patient. When this patient was identified as having an NDM-1 *Escherichia coli* infection, the subject had a rectal swab done as part of contact screening, as per the hospital protocol. Whole-genome sequencing (WGS) was performed on the NDM-1 *E. coli* isolate. Phenotypic characterization of the isolate identified resistance to at least 17 clinically used antibiotics, including second- and third-generation cephalosporins and carbapenems, but it remained susceptible to gentamicin and polymyxin B.

Genomic DNA was extracted from an overnight culture using MagNA Pure Compact (Roche Applied Science, Germany), and the Illumina Nextera XT sample prep kit was used to prepare the sequencing library for WGS on the Illumina MiSeq platform, generating 848,394 pass-filtered 250-bp paired-end reads. *De novo* assembly was performed using Velvet, with a *k*-mer value of 63, producing 242 contigs with a total length of 5,258,026 bp and an N~50~ of 90,507 bp. The contigs were then searched against the NCBI NT database (<http://www.ncbi.nlm.nih.gov/genbank/index.html>) using BLAST ([@B4]), identifying strain NA114 (accession no. CP002797.2) as the most probable *E. coli* strain, with a genomic coverage of 88.7%. Additionally, three circular plasmids were identified, with minimum 90% genomic coverage. Strains PECOS88 (accession no. CU928146.1) and pG-09EL71 (accession no. CP003303.1) were previously identified as *E. coli*. Interestingly, the third plasmid shares complete 100% identity with the NDM-1-encoding plasmid pTR3 (accession no. JQ349086.2), which was reported to be isolated from a patient admitted into another hospital in Singapore ([@B5]). This finding suggests possible epidemiological links between the two plasmids.

Resistance Gene Identifier (Institute of Infectious Disease Research, McMaster University \[<http://arpcard.mcmaster.ca>\]) was used to identify antibiotic resistance genes present in the isolate that showed complete concordance with the phenotypic results achieved by predicting resistance to β-lactams, tetracycline, rifampin, macrolides, sulfonamides, and fluoroquinolones ([@B6]). This demonstrated the utility of WGS for the identification of species and resistance to antibiotics with a single and more efficient workflow in clinical microbiology settings.

Further studies on the NDM-1-producing *E. coli* and other nosocomial multidrug-resistant bacterial isolates obtained from patients in Singapore are currently under way. These data may shed important light on the molecular mechanisms contributing to bacterial drug resistance dissemination and help guide preventive measures for hospital transmission.

Nucleotide sequence accession numbers. {#h1}
--------------------------------------

This whole-genome shotgun project has been deposited in EMBL under the accession no. [CBVN010000001](http://www.ncbi.nlm.nih.gov/nuccore?term=CBVN010000001) to [CBVN010000242](http://www.ncbi.nlm.nih.gov/nuccore?term=CBVN010000242).
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